Cargando...
Future concepts in bronchodilation for COPD: dual- versus monotherapy
Most patients with COPD are recommended to initiate maintenance therapy with a single long-acting bronchodilator, such as a long-acting muscarinic antagonist or long-acting β(2)-agonist. However, many patients receiving mono-bronchodilation continue to experience high symptom burden, suggesting that...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artigo Texto |
| Idioma: | English |
| Publicado: |
European Respiratory Society
2021
|
| Materias: | |
| Acceso en liña: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489138/ https://www.ncbi.nlm.nih.gov/pubmed/34415847 http://dx.doi.org/10.1183/16000617.0023-2021 |